SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001829126-23-004521
Filing Date
2023-06-30
Accepted
2023-06-30 16:05:14
Documents
1
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 ownership.html 4  
1 FORM 4 ownership.xml 4 5090
  Complete submission text file 0001829126-23-004521.txt   6717
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Issuer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GELESIS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address
Leider Harry L. (Reporting) CIK: 0001888273 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55008 | Film No.: 231061672